Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

Immune System Diseases Clinical Trial

— GAP  

Official title:

Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01161056
• Other study ID #: 09-081A
• Secondary ID: 1RC2AR059092-01
• Status: Completed
• Phase: N/A
• First received: July 9, 2010
• Last updated: September 9, 2015
• Start date: May 2009
• Est. completion date: April 2015

Study information

• Verified date: September 2015
• Source: Northwell Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

Description:

The primary purpose of this research is to develop a better understanding of how the immune system works. By studying immune function in many people, we will be able to determine the range of normal variation.

The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).

Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5000
• Est. completion date: April 2015
• Est. primary completion date: April 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Over age 18

• Generally healthy

Exclusion Criteria:

• History of autoimmune disease

• History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV

• Currently undergoing treatment for cancer

• Current treatment with immuno-suppressant drugs

• Pregnancy

Study Design

N/A

Related Conditions & MeSH terms

• Immune System Diseases

Locations

Country	Name	City	State
United States	The Feinstein Institute for Medical Research	Manhasset	New York

Sponsors (3)

Lead Sponsor	Collaborator
Northwell Health	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of healthy participants enrolled	This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control	5 years	No